Prolactin secretion in man following acute and long-term cimetidine administration

Acta Endocrinol (Copenh). 1980 Apr;93(4):392-5. doi: 10.1530/acta.0.0930392.

Abstract

In 20 patients with duodenal ulcer we measured serum prolactin levels following acute and long-term cimetidine administration. In addition, in 20 healthy volunteers we studied the effect of pre-treatment with bromocriptine, meterogline, nomifensine and cryroheptadine on cimetidine-induced prolactin release. Intravenous cimetidine stimulated prolactin secretion in patients and in normal subjects. In the latter, bromocroptine and metergoline pre-administration blunted the release of prolactin in response to iv cimetidine whereas nomifensine and cyproheptadine were ineffective. Long-term treatment with cimetidine (1.2 g daily for 3 months) had no effect on prolactin secretion in the 20 patients studied. No incidence of gynaecomastia, galactorrhoea or disorders of the menstual cycle was observed.

MeSH terms

  • Adult
  • Bromocriptine / pharmacology
  • Cimetidine / pharmacology*
  • Cyproheptadine / pharmacology
  • Duodenal Ulcer / drug therapy
  • Duodenal Ulcer / physiopathology
  • Female
  • Guanidines / pharmacology*
  • Humans
  • Male
  • Metergoline / pharmacology
  • Nomifensine / pharmacology
  • Prolactin / blood
  • Prolactin / metabolism*
  • Secretory Rate / drug effects
  • Time Factors

Substances

  • Guanidines
  • Metergoline
  • Nomifensine
  • Cyproheptadine
  • Bromocriptine
  • Cimetidine
  • Prolactin